Accumulating clinical data on PCSK9 inhibition: What are the key lessons? - PACE-CME

Accumulating clinical data on PCSK inhibition What are the key lessons

Media formats available:

Ready to Claim Your Credits?

You have attempts to pass this post-test. Take your time and review carefully before submitting.

Good luck!

Recommended

Phase 3 study results of plozasiran in patients with FCS
Phase 3 study results of plozasiran in patients with FCS
Hyperlipidemia
Phase 3 study results of plozasiran in patients with FCS
- Gerald F. Watts, DSc, DM, PhD
New ESC Guidelines for CCS and PAAD
New ESC Guidelines for CCS and PAAD
ESC Congress 2024
New ESC Guidelines for CCS and PAAD
- Pierre Sabouret, MD, PhD
Favorable effects of evolocumab on plaque characteristics in severe carotic artery stenosis
Favorable effects of evolocumab on plaque characteristics in severe carotic artery stenosis
ESC Congress 2024
Favorable effects of evolocumab on plaque characteristics in severe carotic artery stenosis
- C. David Mazer, MD
Lp(a) in patients with recent CHD
Lp(a) in patients with recent CHD
ESC Congress 2024
Lp(a) in patients with recent CHD
- Prof. Kausik Ray, MBChB, MD, MPhil